Table 1

Studies selected for meta-analysis of the modulation of age at onset in SCA3/MJD by CAG repeat length at ATXN3 and additional factors

CohortN, published*N, available†Data typeQC programme‡Available data (risk factors)Reference
Rio Grande do Sul, Brazil463507IPDYesFamily, gender, origin, ATXN3, ATXN1, ATXN2, CACNA1A, ATXN7 Souza et al 23 2016
EUROSCA,
Europe
403403IPDYesFamily, gender, origin, ATXN3, ATXN1, ATXN2, CACNA1A, ATXN7 Tezenas du Montcel et al 6 2014
Taiwan48347IPDNSGender, origin, ATXN3 Wang et al 19 2012
Portugal (Mainland)48226IPDYesOrigin, ATXN3 Silveira et al 17 1998
China141141IPDNSFamily, origin,
ATXN3 (expanded allele only)
Wang et al 20 2017
Netherlands342§133IPDYesFamily, origin, ATXN3 van de Warrenburg et al 18 2005
São Paulo, Brazil34110IPDNoOrigin,
ATXN3 (expanded allele only)
França Jr et al 22 2009
Portugal
(Azorean Islands)
93106IPDYesFamily, gender, origin, ATXN3, ATXN1, ATXN2, CACNA1A, ATXN7 Raposo et al 7 2015
Neurogenetics network, Brazil481¶104IPDYesFamily, gender, origin, ATXN3, ATXN1, ATXN2, CACNA1A, ATXN7 de Castilhos et al 5 2014
Cuba2222IPDYesOrigin, ATXN3 González-Zaldívar et al 21 2015
China802ADNSOrigin,
ATXN3 (expanded allele only)
Chen et al 8 2016
USA110ADNSOrigin,
ATXN3 (expanded allele only)
Tezenas du Montcel et al 6 2014
  • *Number of patients reported on the original publication.

  • †Number of patients whose data were obtained after contacting the corresponding author of the selected publication.

  • ‡Participation in molecular diagnosis quality control programme.

  • §This study reports on Dutch and French patients, but only the Dutch cohort was available for analysis.

  • ¶This study includes patients from the Rio Grande do Sul cohort, but only patients from other Brazilian regions were retrieved for analysis.

  • AD, aggregated database; EUROSCA, European Consortium on Spinocerebellar Ataxias; IPD, individual-participant database; NS, not specified; SCA3/MJD, spinocerebellar ataxia type 3/Machado-Joseph disease.